骨生物製剤市場：製品、技術、加工方法、供給材料、用途、エンドユーザー別-2025～2030年世界予測

骨生物製剤市場は、2023年に12億9,000万米ドルと評価され、2024年には13億6,000万米ドルに達すると予測され、CAGR 5.47％で成長し、2030年には18億8,000万米ドルになると予測されています。

骨生物製剤は、より広範な生体材料市場のサブセットであり、骨の治癒、再生、修復を促進する製品を包含します。これらには、骨移植代替物、成長因子、細胞足場が含まれ、整形外科手術や歯科手術において重要な役割を果たしています。骨生物製剤の需要を牽引しているのは、骨粗鬆症や変形性関節症などの骨疾患の有病率の上昇、高齢化人口の増加、外科手術の進歩です。主要用途は、脊椎固定術、外傷固定術、自然治癒が不十分な再建手術などです。病院、専門クリニック、研究機関が、骨生物製剤製品の1次エンドユーザーです。重要な市場開拓要因としては、材料科学や生体工学の技術進歩、研究開発投資の増加、低侵襲手術手技への注目の高まりなどが挙げられます。天然骨の特性をより忠実に模倣した合成骨移植片の開発や、カスタマイズインプラントのための3Dプリンティング技術の革新から、ビジネス機会が生まれつつあります。推奨事項としては、満たされていない臨床ニーズに対応するための強固な製品パイプライン開発に注力すること、市場浸透を強化するために医療機関との戦略的パートナーシップを追求することなどが挙げられます。しかし、骨生物製剤の高価格、厳しい規制の枠組み、免疫反応や拒絶反応のリスクといった課題が市場の成長を制限しています。さらに、製品の標準化に関する複雑さや長い承認スケジュールが、迅速な技術革新を妨げています。こうした障壁を克服するために、企業は費用対効果の高い製造技術に投資し、規制当局の承認を合理化するための共同研究開発に取り組むべきです。この市場の競争は激しく、科学的進歩が重視され、骨生物製剤の利点に対する消費者の認識も高まっています。生物活性材料や、優れた結果をもたらす生物学的成分と合成成分を組み合わせた混合使用療法には、技術革新の余地がかなりあり、市場拡大と差別化のための有利な道を提示しています。

市場力学：急速に進化する骨生物製剤市場の主要市場洞察を公開

骨生物製剤市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の高齢化人口の増加と骨関連疾患の有病率の上昇
  • 先進的骨治癒ソリューションが必要とされる、骨や関節に関わる外科手術の増加
  • 低侵襲治療への需要の高まり
• 市場抑制要因
  • 製品の信頼性と受容性に影響する臨床結果のばらつき
• 市場機会
  • 3Dプリンティングと組織工学を用いた患者固有の治療法の開発
  • 有効性を高めるための新規材料や生物学的薬剤の組み合わせを含む製品ラインの拡大
• 市場課題
  • 認知度の低さと熟練した専門家の不足

ポーターのファイブフォース：骨生物製剤市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：骨生物製剤市場における外部からの影響の把握

外部マクロ環境要因は、骨生物製剤市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：骨生物製剤市場における競合情勢の把握

骨生物製剤市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：骨生物製剤市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、骨生物製剤市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：骨生物製剤市場における成功への道筋を描く

骨生物製剤市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界的に高齢化が進み、骨関連疾患の罹患率も上昇
    • 骨や関節に関わる外科的介入が増加し、先進的骨治癒ソリューションが必要になっている
    • 低侵襲治療の需要の高まり
  • 抑制要因
    • 製品の信頼性と受容性に影響を与える臨床結果の変動
  • 機会
    • 3Dプリンティングと組織工学を用いた患者固有の治療法の開発
    • 有効性を高めるための新しい材料と生物学的薬剤の組み合わせを含む製品ラインの拡大
  • 課題
    • 認識の低さと熟練した専門家の不足
• 市場セグメンテーション分析
  • 製品：新しい骨の成長をサポートする骨伝導特性による同種移植の新たな用途
  • 用途：骨の感染症と腫瘍を標的とした抗菌性と再生特性を兼ね備えた骨生物学的ソリューションの必要性
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 骨生物製剤市場：製品別

• イントロダクション
• 同種移植
• 骨髄穿刺濃縮液
• 骨形成タンパク質
• 脱灰骨基質
• 血漿タンパク質
• 合成オーソバイオロジクス
• 粘性サプリメント製品

第7章 骨生物製剤市場：技術別

• イントロダクション
• バイオセラミックと複合材料
• 注入可能生体材料
• 整形外科用生体材料インプラント

第8章 骨生物製剤市場：加工方法別

• イントロダクション
• 脱塩
• 鉱化
• 骨伝導性
• 骨誘導性

第9章 骨生物製剤市場：供給材料別

• イントロダクション
• 天然
• 合成

第10章 骨生物製剤市場：用途別

• イントロダクション
• 骨の感染症と腫瘍
• 歯科骨移植
• 関節再建
• 脊椎固定術
• 外傷と癒合不全骨折

第11章 骨生物製剤市場：エンドユーザー別

• イントロダクション
• 病院
• 研究・学術機関
• 専門クリニック

第12章 南北アメリカの骨生物製剤市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋の骨生物製剤市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカの骨生物製剤市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • Biogennix、牛のコラーゲンから作られたアギロン外科用マトリックスを発売
  • Biogennix、アギロンとモーフィアスモールダブル製品でFDA認可を取得
  • アーバインに拠点を置くバイオジェニックスが手術結果を向上させるオステオスパン繊維マトリックスを発売
• 戦略分析と提言

企業一覧

• Advancells Diagnostics
• Aetna Inc.
• AlloSource
• Anika Therapeutics, Inc.
• Arthrex, Inc.
• Australian BIoTechnologies Pty Ltd
• Baxter International Inc.
• Biogennix, LLC.
• CONMED Corporation
• Exactech, Inc.（TPG Capitalが親会社）
• Geistlich Pharma AG
• Integra LifeSciences Holdings Corporation
• KLS Martin Group
• KNITPRO INTERNATIONAL
• Medical Device Business Services, Inc.
• Medtronic Plc
• MTF Biologics
• NuVasive, Inc.
• Orthofix Medical Inc.
• Osiris Therapeutics, Inc.（Smith & Nephewによる買収）
• ROYAL BIOLOGICS
• RTI Surgical Holdings, Inc.（Montagu Private Equity LLPによる買収）
• Stryker Corporation
• SynerHeal Pharmaceuticals
• Wright Medical Group N.V.
• Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

• FIGURE 1. OSTEOBIOLOGICS MARKET RESEARCH PROCESS
• FIGURE 2. OSTEOBIOLOGICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL OSTEOBIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 21. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 26. OSTEOBIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 27. OSTEOBIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. OSTEOBIOLOGICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL OSTEOBIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. OSTEOBIOLOGICS MARKET DYNAMICS
• TABLE 7. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BONE MARROW ASPIRATE CONCENTRATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENIC PROTEIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PLASMA-RICH PROTEIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC ORTHOBIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY VISCO-SUPPLEMENTATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BIOCERAMICS & COMPOSITES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY INJECTABLE BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY ORTHOPEDIC BIOMATERIAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MINERALIZED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY OSTEOCONDUCTIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY OSTEOINDUCTIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BONE INFECTION & TUMORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DENTAL BONE GRAFTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & NON-UNION FRACTURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. CANADA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. CANADA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 58. CANADA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 59. CANADA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 60. CANADA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. CANADA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 85. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 86. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. CHINA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. CHINA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 90. CHINA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 91. CHINA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 92. CHINA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. CHINA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. INDIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. INDIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 96. INDIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 97. INDIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 98. INDIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. INDIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 102. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 103. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 104. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 108. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 109. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 110. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 114. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 115. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 116. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 120. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 121. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 122. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 126. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 127. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 128. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 134. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 138. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 139. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 140. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 144. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 145. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 146. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 150. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 151. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 152. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 163. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 164. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 165. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 169. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 170. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 171. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 175. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 176. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 177. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 180. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 181. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 182. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 183. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 187. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 188. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 189. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 192. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 193. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 194. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 195. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. ITALY OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 198. ITALY OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 199. ITALY OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 200. ITALY OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 201. ITALY OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. ITALY OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 204. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 205. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 206. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 207. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 208. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 210. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 211. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 212. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 213. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 214. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 216. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 217. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 218. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 219. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 220. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 221. POLAND OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 222. POLAND OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 223. POLAND OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 224. POLAND OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 225. POLAND OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. POLAND OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 227. QATAR OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 228. QATAR OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 229. QATAR OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 230. QATAR OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 231. QATAR OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. QATAR OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 234. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 235. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 236. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 237. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 238. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 240. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 242. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 243. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 244. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 248. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 249. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 250. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 252. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 253. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 254. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 255. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 256. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 258. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 259. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 260. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 261. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 262. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 264. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 265. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 266. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 267. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 268. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 270. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 271. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 272. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 273. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 274. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 278. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 279. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 280. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 282. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
• TABLE 284. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
• TABLE 285. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 286. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 287. OSTEOBIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 288. OSTEOBIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023

The Osteobiologics Market was valued at USD 1.29 billion in 2023, expected to reach USD 1.36 billion in 2024, and is projected to grow at a CAGR of 5.47%, to USD 1.88 billion by 2030.

Osteobiologics, a subset of the broader biomaterials market, encompass products that promote bone healing, regeneration, and repair. These include bone graft substitutes, growth factors, and cellular scaffolds, playing crucial roles in orthopedic and dental surgeries. The demand for osteobiologics is driven by the rising prevalence of bone disorders such as osteoporosis and osteoarthritis, the growing aging population, and advancements in surgical procedures. Key applications lie in spinal fusion, trauma fixation, and reconstructive surgeries where natural bone healing is insufficient. Hospitals, specialized clinics, and research institutions comprise the primary end-users of osteobiologics products. Significant market growth factors include technological advancements in material science and bioengineering, increased investment in research and development, and a rising focus on minimally invasive surgical techniques. Opportunities are emerging from developing synthetic bone grafts that mimic natural bone properties more closely and innovations in 3D printing technology for customized implants. Recommendations include focusing on robust product pipeline development to address unmet clinical needs and pursuing strategic partnerships with healthcare institutions for enhanced market penetration. However, challenges such as the high cost of osteobiologic products, stringent regulatory frameworks, and the risk of immune response or rejection limit market growth. Furthermore, complexities related to product standardization and long approval timelines impede rapid innovation. To overcome these barriers, companies should invest in cost-effective manufacturing technologies and engage in collaborative R&D to streamline regulatory approvals. The nature of this market is highly competitive, with a strong emphasis on scientific advancement and increased consumer awareness about the benefits of osteobiologics. There is considerable scope for innovation in bioactive materials and mixed-use therapies combining biological and synthetic components for superior outcomes, presenting lucrative avenues for market expansion and differentiation.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Osteobiologics Market

The Osteobiologics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing aging population globally and rising prevalence of bone-related conditions
  • Rising surgical interventions involving bones and joints necessitating advanced bone healing solutions
  • Growing demand for minimally invasive treatments
• Market Restraints
  • Variability in clinical outcomes affecting the credibility and acceptance of products
• Market Opportunities
  • Development of patient-specific treatments using 3D printing and tissue engineering
  • Expansion of product lines to include novel materials and combinations of biological agents for enhanced efficacy
• Market Challenges
  • Limited awareness and dearth of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Osteobiologics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Osteobiologics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Osteobiologics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Osteobiologics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Osteobiologics Market

A detailed market share analysis in the Osteobiologics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Osteobiologics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Osteobiologics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Osteobiologics Market

A strategic analysis of the Osteobiologics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Osteobiologics Market, highlighting leading vendors and their innovative profiles. These include Advancells Diagnostics, Aetna Inc., AlloSource, Anika Therapeutics, Inc., Arthrex, Inc., Australian Biotechnologies Pty Ltd, Baxter International Inc., Biogennix, LLC., CONMED Corporation, Exactech, Inc.(parent company TPG Capital), Geistlich Pharma AG, Integra LifeSciences Holdings Corporation, KLS Martin Group, KNITPRO INTERNATIONAL, Medical Device Business Services, Inc., Medtronic Plc, MTF Biologics, NuVasive, Inc., Orthofix Medical Inc., Osiris Therapeutics, Inc. (acquired by Smith & Nephew), ROYAL BIOLOGICS, RTI Surgical Holdings, Inc.(acquired by Montagu Private Equity LLP), Stryker Corporation, SynerHeal Pharmaceuticals, Wright Medical Group N.V., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Osteobiologics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Allografts, Bone Marrow Aspirate Concentrate, Bone Morphogenic Protein, Demineralized Bone Matrices, Plasma-Rich Protein, Synthetic Orthobiologics, and Visco-Supplementation Products.
• Based on Technique, market is studied across Bioceramics & Composites, Injectable Biomaterials, and Orthopedic Biomaterial Implants.
• Based on Processing Method, market is studied across Demineralized, Mineralized, Osteoconductive, and Osteoinductive.
• Based on Material Sourced, market is studied across Natural and Synthetic.
• Based on Application, market is studied across Bone Infection & Tumors, Dental Bone Grafting, Joint Reconstruction, Spinal Fusion, and Trauma & Non-Union Fractures.
• Based on End-User, market is studied across Hospitals, Research & Academic Institutes, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing aging population globally and rising prevalence of bone-related conditions
    • 5.1.1.2. Rising surgical interventions involving bones and joints necessitating advanced bone healing solutions
    • 5.1.1.3. Growing demand for minimally invasive treatments
  • 5.1.2. Restraints
    • 5.1.2.1. Variability in clinical outcomes affecting the credibility and acceptance of products
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of patient-specific treatments using 3D printing and tissue engineering
    • 5.1.3.2. Expansion of product lines to include novel materials and combinations of biological agents for enhanced efficacy
  • 5.1.4. Challenges
    • 5.1.4.1. Limited awareness and dearth of skilled professionals
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Emerging usage of allografts owing to their osteoconductive properties that support new bone growth
  • 5.2.2. Application: Need for osteobiologic solutions that combine antimicrobial and regenerative properties for targeting bone infection & tumors
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Osteobiologics Market, by Product

• 6.1. Introduction
• 6.2. Allografts
• 6.3. Bone Marrow Aspirate Concentrate
• 6.4. Bone Morphogenic Protein
• 6.5. Demineralized Bone Matrices
• 6.6. Plasma-Rich Protein
• 6.7. Synthetic Orthobiologics
• 6.8. Visco-Supplementation Products

7. Osteobiologics Market, by Technique

• 7.1. Introduction
• 7.2. Bioceramics & Composites
• 7.3. Injectable Biomaterials
• 7.4. Orthopedic Biomaterial Implants

8. Osteobiologics Market, by Processing Method

• 8.1. Introduction
• 8.2. Demineralized
• 8.3. Mineralized
• 8.4. Osteoconductive
• 8.5. Osteoinductive

9. Osteobiologics Market, by Material Sourced

• 9.1. Introduction
• 9.2. Natural
• 9.3. Synthetic

10. Osteobiologics Market, by Application

• 10.1. Introduction
• 10.2. Bone Infection & Tumors
• 10.3. Dental Bone Grafting
• 10.4. Joint Reconstruction
• 10.5. Spinal Fusion
• 10.6. Trauma & Non-Union Fractures

11. Osteobiologics Market, by End-User

• 11.1. Introduction
• 11.2. Hospitals
• 11.3. Research & Academic Institutes
• 11.4. Specialty Clinics

12. Americas Osteobiologics Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Osteobiologics Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Osteobiologics Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
  • 15.3.1. Biogennix launches Agilon Surgical Matrix made from bovine collagen
  • 15.3.2. Biogennix receives FDA clearance for Agilon and Morpheus Moldable products
  • 15.3.3. Irvine-based biogennix launches osteospan fiber matrix to enhance surgical outcomes
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Advancells Diagnostics
• 2. Aetna Inc.
• 3. AlloSource
• 4. Anika Therapeutics, Inc.
• 5. Arthrex, Inc.
• 6. Australian Biotechnologies Pty Ltd
• 7. Baxter International Inc.
• 8. Biogennix, LLC.
• 9. CONMED Corporation
• 10. Exactech, Inc.(parent company TPG Capital)
• 11. Geistlich Pharma AG
• 12. Integra LifeSciences Holdings Corporation
• 13. KLS Martin Group
• 14. KNITPRO INTERNATIONAL
• 15. Medical Device Business Services, Inc.
• 16. Medtronic Plc
• 17. MTF Biologics
• 18. NuVasive, Inc.
• 19. Orthofix Medical Inc.
• 20. Osiris Therapeutics, Inc. (acquired by Smith & Nephew)
• 21. ROYAL BIOLOGICS
• 22. RTI Surgical Holdings, Inc.(acquired by Montagu Private Equity LLP)
• 23. Stryker Corporation
• 24. SynerHeal Pharmaceuticals
• 25. Wright Medical Group N.V.
• 26. Zimmer Biomet Holdings, Inc.